Unigene Laboratories Inc - Company Profile and News
Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the research, production and delivery of small proteins, referred to as peptides, for medical use. The Company has patented ...
Company Unigene Laboratories, Inc. News, Employees and
Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence™ encompasses extensive intellectual property covering drug delivery and manufacturing technologies, unsurpassed ...
Company Profile - Unigen
Unigen’s extensive plant library currently contains over 10,000 plants and 175,000 fractions which are screened using the PhytoLogix™ process to discover novel compounds. Since 1996, Unigen has been continually updating and screening our plant library, with currently over 8,000 plant extracts, we have developed a unique array of ingredients ...
Company Bankruptcy Information for Unigene Laboratories
Jul 02, 2013 · Unigene Laboratories, Inc. 83 Fulton Street Boonton, NJ 07005 MORRIS-NJ Tax ID / EIN: xx-xxx8609 Represented By. Lauren Silver Zabel Reed Smith LLP Three Logan Square 1717 Arch Street, Suite 3100 Philadelphia, PA 19103 215-851-8147 Fax : 215-851-1420 Email: [email protected] Trustee. Nancy Isaacson Greenbaum, Rowe, Smith & Davis LLP
Unigene Laboratories - Wikipedia
Unigene Laboratories (OTC:UGNE) was a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey. The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis.The company has licensed worldwide rights to its oral parathyroid hormone ...
Unigene Claims $64.2M Liabilities In Ch. 7 Petition - Law360
New Jersey-based Unigene Laboratories filed for Chapter 7 bankruptcy on Tuesday, declaring $64.2 million in liabilities after defaulting on repayments to a private equity firm and the company's ...
Exhibit 10.1 Joint Venture Contract
Jun 15, 2000 · Exhibit 10.1 Joint Venture Contract for UNIGENE LABORATORIES INC, Chapter II CONTRACTING PARTIES, Shijiazhuang Pharmaceutical Group Company, Ltd, Unigene Laboratories, Inc, UNIGENE PHARMACEUTICAL CORPORATION LIMITED - Sample agreements, legal documents, and contracts from RealDealDocs.
UNIGEN CORPORATION ... ___UNIGEM - California business
Sep 27, 1991 · Status: Inactive Registration: Jun 30, 1982 State ID: 73372345 Reg. number: 1264542 Status: 710 - Cancelled - section 8 Status date: Oct 23, 2004 Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Employee: Dominick J Salemi Goods & Services: No claim is made to the exclusive right to use the word "international", apart from the mark as shown., Retail jewelry ...
Unigene Laboratories Inc in Fairfield, NJ with Reviews
Unigene Laboratories Inc. Research & Development Labs. Website. (973) 882-0860. 75 Livingston Ave. Roseland, NJ 07068. From Business: Unigene Laboratories is a biopharmaceutical company engaged in the research, production and delivery of small proteins, referred to as peptides, which have….
Unigene Laboratories and similar companies | Frankensaurus.com
Unigene Laboratories is similar to these companies: MorphoSys, Gilead Sciences, Amarin Corporation and more. Topic. Unigene Laboratories. Share. Companies similar to or like Unigene Laboratories. Biopharmaceutical company, engaged in the research and development of peptides for …
Unigene Laboratories - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (973) 265-1100 Founded in 1980, Unigene is a publicly traded biopharmaceutical company with corporate offices, an R&D facility and a state-of-the-art recombinant manufacturing facility in New Jersey.
Unigenes - an overview | ScienceDirect Topics
Andrew Buchanan, Jefferson D. Revell, in Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies, 2015. Peptelligence™ Having acquired the Peptelligence™ platform and a recombinant manufacturing process for therapeutically relevant peptides from Unigene Laboratories, Enteris Biopharma has become an industry leader in oral dosage formulations.
Identification of Novel Alpha Amidated Peptide ... - SBIR.gov
Identification of these novel a-amidated peptide hormones will lead to an increased understanding of cellular signaling pathways and to the role played by the a-amidated peptides in human disease. The novel a-amidated peptides uncovered by our innovative assay could also lead to new therapeutics for the treatment of human disease and/or new ...
What did Unigene Laboratories do for a living?
Unigene Laboratories(OTC:UGNE) was a biopharmaceuticalcompany, engaged in the research and development of peptidesfor medical purposes. The company was founded in 1980 and is located in New Jersey. The company's primary focus is on the development of calcitoninand related peptides for the treatment of osteoporosis.